As our knowledge of science and the human body expands, so too do doctors have more tools at hand when treating cancer. One relatively recent development in this sphere is the use of oncolytic virus therapy, which — as its name suggests — involves using a customized virus to target tumors in the human body, then letting the body’s immune system go to work.
As Saima Sidik reports at Nature, a group of doctors largely based at multiple medical facilities in Nanning, China embarked on a study that echoed the behavior of the body when it rejects a transplanted organ. According to Nature, scientist Yongxiang Zhao drew inspiration from the way the human immune system reacts to transplanted pig organs. (Some successful xenotransplantations have taken place, but recently they’ve involved genetically modified…